Egualen sodium hydrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEgualen sodium hydrate
Drug Alias NameEgualen SodiumAzuletil sodiumAzuloxaKT1-32KTI-32
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsStomach Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1999/03/12
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKotobuki
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsStomach Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeA02B
Related LinksKEGG